Monday, December 22, 2025
DarioHealth Corp., a leader in global digital health, today announced the launch of the Dario Health app enhanced with DarioIQ™, the Company's new artificial intelligence ("AI") layer, delivered as a direct-to-consumer first version for an initial cohort of hypertension members who enrolled to access the new experience. This launch marks the first major milestone in Dario's multi-phase introduction of conversational AI designed to enhance, not replace, the human-centered guidance central to chronic condition management.
The introduction of DarioIQ™ adds a clinically aligned, conversational layer that operates side-by-side with Dario's data and experience-driven mobile application. The system integrates behavioral insights, real-time biometric interpretation and personalized guidance, supported by seamless medical-device connectivity and Dario's existing human coaching framework. This deployment represents a foundational step in Dario's evolutionary GenAI roadmap, with patient safety at the forefront.
Dario began with a direct-to-consumer hypertension support to anchor DarioIQ™ in a high-impact condition area while refining the integrated conversational experience, before expanding across the full suite of Dario solutions for employers and health plans. This phase will inform expansion across diabetes, weight management, behavioral health, musculoskeletal conditions and additional chronic pathways.
Members in the initial cohort opted in specifically to use the enhanced experience, ensuring transparency and maintaining trust in the company's introduction of DarioIQ™.
Dario selected its direct-to-consumer marketspace to refine user interactions and evaluate safety and performance within a controlled, mature ecosystem. This approach allows Dario to bring a fully validated, evidence-supported AI capability to its business-to-business ("B2B") partners – avoiding risks associated with unproven or hypothetical generative models.
"The introduction of DarioIQ™ into the hands of real hypertension users represents a major moment for Dario," said Lara Dodo, Chief Operating Officer at Dario. "Our AI is intentionally designed to complement, and not replace, the human experience of managing chronic conditions. By launching a direct-to-consumer first version, we will be able to learn from real engagement, ensure safety and clinical alignment, and deliver a mature, evidence-based capability to our employer and payer partners. This is the foundation for the unified GenAI experience that will power the next generation of Dario's platform."
DarioIQ™ combines three AI-driven components: Advisor, which delivers personalized guidance; Sentinel, which provides timely interventions to keep users engaged; and Strategist, which turns member data into actionable insights and measurable value. These capabilities build on Dario's proprietary AI models and over 13 billion real-world data points, reinforcing Dario's position as a leader in digital health.
"DarioIQ™ reflects years of innovation in data science, engineering and clinical design," said Galya Gorodinsky, Senior Vice President, Research and Development, and Delivery Solutions. "Starting with hypertension allows us to validate the full experience – from device data interpretation to adaptive, conversational guidance – while maintaining clear safety guardrails. This rollout ensures operational stability as we extend AI throughout Dario's growing ecosystem."
To join our expert panel discussions, reach out to info@intentamplify.com
Recommended News
Source – prnewswire
pdfFiller launches Chat with PDF, an AI-powered conversational tool that turns static documents into interactive experiences with instant insights and citations.
Dialpad partners with the Florida Panthers to introduce real-time AI and unified communications, boosting collaboration, decision speed, and operational efficiency.
